This study evaluated the effects of a combined ethanol extract of and Hypselodelphys poggeana and Spermacoce radiata
leaves (CESHL) on sex hormone levels and prostate weights of benign prostatic hyperplasia (BPH) induced rats. The
combined extract was prepared from the plants and was subjected to acute toxicity (LD50) evaluation in rats. The study
adopted five groups of rats (n = 6) with group 1 being the normal control without BPH induction, group 2 was the BPH
control, group 3 was the finasteride control, and groups 4 and 5 were BPH induced rats treated with 250 and 500 mg/kg
CESHL/day for 28 days. Induction of prostate hyperplasia in rats belonging to groups 2-5 was done via daily
subcutaneous administration of testosterone propionate (5 mg/kg body weight) for 28 days in accordance with
standard protocols. The result obtained in the acute toxicity evaluation indicated an LD50 value of above 5000 mg/kg
body weight. In the main study, a significant increase (P<0.05) in serum testosterone, dihydrotestosterone, prostate
weight, prostate index and reduced serum estradiol was observed in the BPH control when compared with the normal
control. Treatment of BPH induced rats (groups 4 and 5) with CESHL significantly reduced serum concentrations of
testosterone and dihydrotestosterone, and also elevated serum estradiol concentration when compared with the BPH
control, comparing favourably with the values of these hormones in the finasteride-treated group. The BPH induced
rats treated with CESHL also had significantly reduced prostate weight and prostate index relative to the BPH control
and higher percentage inhibition of prostate weight and prostate index when compared with the finasteride control.
Our findings show that CESHL may ameliorate benign prostate hyperplasia via mechanisms that lower serum
testosterone and dihydrotestosterone levels and increase estradiol levels.
Benign prostatic hyperplasia Spermacoce radiata Hypselodelphy spoggeana Sex hormones Prostate weight Prostate index
Primary Language | English |
---|---|
Subjects | Pharmaceutical Biochemistry |
Journal Section | Articles |
Authors | |
Publication Date | June 28, 2025 |
Published in Issue | Year 2022 Volume: 26 Issue: 4 |